Condition: Breast Cancer · Sponsor: Hoffmann-La Roche
This study will evaluate the safety and efficacy of inavolisib combination therapies in participants with untreated, PIK3CA-mutated, Stage II-III, estrogen receptor (ER)-positive, Human Epidermal Growth Factor Receptor 2 (HER2)-negative breast cancer (BC).
This description comes directly from the study's public registry record.
Reference Study ID Number: BO45853 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. and Canada) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| Los Angeles Cancer Network | Los Angeles, California, United States | Recruiting |
| Community Clinical Trials | Orange, California, United States | Recruiting |
| West Cancer Center | Germantown, Tennessee, United States | Recruiting |
| West Virginia University | Morgantown, West Virginia, United States | Recruiting |
| Hospital Aleman de Buenos Aires | Buenos Aires, Argentina | Recruiting |
| Centro Médico Fleischer | Buenos Aires, Argentina | Recruiting |
| Centro Oncologico Korben | Ciudad Autonoma Buenos Aires, Argentina | Recruiting |
| Hospital Araujo Jorge | Goiânia, Goiás, Brazil | Recruiting |
| Hospital do Cancer de Pernambuco - HCP | Recife, Pernambuco, Brazil | Recruiting |
| Irmandade Da Santa Casa de Misericordia de Porto Alegre | Porto Alegre, Rio Grande do Sul, Brazil | Recruiting |
| Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda | São Paulo, São Paulo, Brazil | Recruiting |
| Sunnybrook Odette Cancer Centre | Toronto, Ontario, Canada | Recruiting |
+ 21 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07054190